Showing 2301-2310 of 4276 results for "".
- Dermalogica Enters Device Market With FDA-Cleared Microneedling Systemhttps://modernaesthetics.com/news/dermalogica-enters-device-market-with-fda-cleared-microneedling-system/2486887/Dermalogica has announced the launch of its PRO Pen Microneedling System following US Food and Drug Administration (FDA) 510(k) clearance, marking the company’s first entry into the medical device category. The device is indicated for the treatment of facial acne scars in adults aged 22 years and
- Micro-Focused Ultrasound Shows Mid-to-Lower Face Tightening in Pilot Studyhttps://modernaesthetics.com/news/micro-focused-ultrasound-shows-mid-to-lower-face-tightening-in-pilot-study/2486847/Micro-focused ultrasound (MFUS) may improve middle and lower facial laxity with a favorable short-term safety profile, according to a prospective pilot study published in Lasers in Medical Science. The single-arm interventional study enrolled 20 Chinese patients with facial laxity. Each pa
- 12-Month Data Support Durability of Click-Crosslinked HA for Nasolabial Foldhttps://modernaesthetics.com/news/12-month-data-support-durability-of-click-crosslinked-ha-for-nasolabial-fold/2486822/A novel long-chain hyaluronic acid (HA) filler utilizing click-chemistry crosslinking demonstrated sustained efficacy and a favorable safety profile for nasolabial fold (NLF) correction in 2 prospective studies published in the Journal of Cosmetic Dermatology. Traditional HA fille
- Revance Highlights RHA Dynamic Volume Mid-Face FDA Approval at Virtual Desk Sidehttps://modernaesthetics.com/news/revance-highlights-rha-dynamic-volume-mid-face-fda-approval-at-virtual-desk-side/2486819/Revance Aesthetics hosted a virtual desk side with Lesley Clark-Loeser, MD, to discuss the recent US Food and Drug Administration (FDA) approval of RHA Dynamic Volume for cheek augmentation and correction of age-related mid-face contour deficiencies in adults aged 22 years and older. The a
- SkinCeuticals Launches Future Mineral UV Defense SPF 50 for Daily and Post-Procedure Usehttps://modernaesthetics.com/news/skinceuticals-launches-future-mineral-uv-defense-spf-50-for-daily-and-post-procedure-use/2486804/SkinCeuticals has introduced Future Mineral UV Defense SPF 50, a new mineral sunscreen designed to provide broad-spectrum UV protection while also addressing visible signs of skin aging, according to the company. The formulation combines 15% zinc oxide and 3% titanium dioxide and is intend
- Hydrafacial Parent Company Rebrands to SkinHealth Systemshttps://modernaesthetics.com/news/hydrafacial-parent-company-rebrands-to-skinhealth-systems/2486793/BeautyHealth Company has announced a corporate rebrand to SkinHealth Systems, reflecting a strategic repositioning toward a clinically oriented, science-backed medical aesthetics platform. The change is effective immediately, with the company continuing to trade on the Nasdaq under its existing t
- Study Evaluates Buccal Fat Pad Flap in Complex Facial Reconstructionhttps://modernaesthetics.com/news/study-evaluates-buccal-fat-pad-flap-in-complex-facial-reconstruction/2486791/A prospective cohort study published online in Aesthetic Plastic Surgery evaluated the reconstructive utility of the buccal fat pad flap in patients undergoing permanent filler removal followed by deep plane facelift. Conducted at a single center in Cairo between 2016 and 2022, the study
- Cell-Assisted Lipotransfer Shows Potential in Facial and Breast Applications, Review Findshttps://modernaesthetics.com/news/cell-assisted-lipotransfer-shows-potential-in-facial-and-breast-applications-review-finds/2486650/Cell-assisted lipotransfer (CAL) continues to evolve as an adjunct to conventional fat grafting, with a recent review in Annali Italiani di Chirurgia summarizing current evidence for its use in facial and breast procedures. CAL involves enrichment of autologous fat grafts with regenerati
- Epicutis Reports 8-Week Clinical Findings for New Hydrobiome Serumhttps://modernaesthetics.com/news/epicutis-reports-8-week-clinical-findings-for-new-hydrobiome-serum/2486634/Epicutis has introduced Hydrobiome Serum, a new professional skincare product positioned for redness, congestion, and barrier disruption. The formulation centers on TCP, a proprietary isoprenyl cysteine compound developed by Signum Biosciences, and is paired with sodium tocopheryl phosphate, a wa
- Acquisition Broadens Newmedical’s Scar Care and Skincare Platformhttps://modernaesthetics.com/news/strategic-acquisition-broadens-newmedicals-scar-care-and-skincare-platform/2486628/Newmedical Technology, Inc. announced its acquisition of Derma Made®, marking a strategic expansion of its dermatology and aesthetics portfolio, according to a news release from the company. The transaction will meld Newmedica